SEC Form 4 · accession 0001179110-18-009933
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Capek
Officer — Executive Vice President
Period of report
Jul 25, 2018
Accepted (ET)
Jul 26, 2018 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Jul 25, 2018 | M | 64,900 | $26.015 | A | 363,200 | D | |
| Common shares without par value | Jul 25, 2018 | S | 64,900 | $65.00 | D | 298,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $26.015 | Jul 25, 2018 | M | 64,900 | D | Feb 20, 2012 | Feb 19, 2019 | Common shares | 64,900 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).